HQ
HealthEquity
HQY · NASDAQ
$96.51 +0.53% (+$0.51)
1M -5.69%
Market Cap $8.07B
P/E Ratio 34.12x
Div. Yield -
ROE 11.43%
Bulios Fair Price
$71.58
25.8% downside
Current Price
$96.51
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HQY is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
51 /100
Fair P/E 34.12x
EV/EBITDA 16.73x
PEG 0.31x
Growth
86 /100
Growing Rev. growth 15.08%
FCF growth 143.50%
Book val. growth 3.59%
Profitability
99 /100
Strong Gross margin 75.21%
Net margin 17.36%
FCF margin 34.63%
Quality
51 /100
Average ROIC 8.99%
ROE 11.43%
Asset turnover 0.42x
Debt
93 /100
Low Debt/Equity 0.02x
Current ratio 2.99x
Net debt/EBITDA -0.46x
Stability
39 /100
Moderate Beta 0.23x
Rev. volatility 5.33%
Profitable years 3
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HQY
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Scott R. Cutler
Employees
2,814
Headquarters
Draper
Upcoming events
02 DEC
Earnings
Upcoming earnings report